Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL Voie d'immunisation et séquence d'administration de l ... - TEL
tel-00827710, version 1 - 29 May 2013 (a) T cell diversity (i) T cell affinity Upon encountering an antigen-presenting DC, T cells that are specific for the epitope presented on MHC-I will proliferate. The strengh of the signal, the environmental conditions and the number of different epitopes presented by DCs will all influence the number of T cell clones that will proliferate. (ii) Memory potential Multiple subsets of effector CD8 + T cells have been identified based on their ability to become memory cells. After antigen clearance, the effector T cell population undergoes a dramatic decrease in numbers, known as the “contraction phase”, mediated mostly by apoptotic cell death. 5-10% of antigen-specific T cells survive this transition and make up the memory T cell pool. This latter subset is characterized by stem-cell-like properties such as slowed cell cycling, longer survival, telomerase expression and the ability of self-renewal. The initial events during T cell activation and signals from the microenvironment during stimulation impact the differentiation of effector T cells toward a terminally differentiated cytotoxic phenotype or toward a memory phenotype. First, the Short-Lived Effectors Cells (SLECs) are characterized by high expression of KLRG1 and low expression of IL-7Rα. These cells exhibit stronger effector function potential. In contrast, the Memory Precursor Effector Cells (MPECs) are KLRG1 low and IL-7Rα high and are more likely to become memory cells (Joshi et al., 2007). Thes distinctions are not absolute, as both subset populations are highly heterogenous. A more accurate depiction of effector CD8 + T cell population heterogeneity would be represented by a continuum with the MPEC phenotype at one extreme, the SLEC at the other extreme, and intermediately differentiated effector cells between these two set phenotypes (Figure 9) (Cui and Kaech, 2010). Several transcription factors have been described that control T cell differentiation. An expression gradient of T-bet has been identified as a critical cell fate decision factor between terminal effector versus memory differentiation and is highly expressed in SLECs (Joshi et al., 2007). In contrast, Eomesodermin (Eomes) acts either in synergy or in opposition with T-bet to favor memory differentiation (Intlekofer et al., 2007; Intlekofer et al., 2005). Other factors such as Blimp-1, Bcl-6 or Id2 have also a role in this mechanism (Cui and Kaech, 2010). Inflammatory signals such as IL-12 can regulate these transcription factors and thus influence the outcome of T cell differentiation in the context of an inflammatory response (Takemoto et al., 2006). 48
tel-00827710, version 1 - 29 May 2013 Figure 9. Effector and memory T cell differentiation upon activation. SLO, secondary lymphoid organ, SLEC, Short-lived effector cell, MPEC, Memory precursor effector cell, TEM, effector memory T cell, TCM, central memory T cell. Figure from Cui et al. 2010. (iii) T cell quality The quality of the T cell response was first characterized by measuring its magnitude, represented by the frequency of antigen-specific T cells and their ability to secrete IFNγ following antigen-specific restimulation using techniques such as IFNγ-ELISPOT. However, the use of only a few parameters to define the quality of the response and its ability to confer a protection is often not sufficient (Seder et al., 2008). For instance, the magnitude of the HIV-specific CD8 + T cell response alone does not predict the progression of the disease (Gea- Banacloche et al., 2000). However, by comparing the T cell responses in patients that are long-term non-progressors to those of progressors, it has been shown that T cell function is not equivalent between these two groups, and that these differences could explain the range of disease progression and outcome phenotypes in these two patient groups. In general, all the effector T cells are not functionally identical. While some T cells secrete only one cytokine such as IFNγ, others are able to secrete several cytokines once activated. These polyfunctional T cells have been demonstrated to be critical for mounting an efficient response in multiple disease models. Practically speaking, T cells can be characterized both by their surface markers expression and also by their various functions, including the ability to secrete cytokines, cytolytic activity or proliferative capacity. The development of more advanced techniques such as Page 49 of 256
- Page 1 and 2: tel-00827710, version 1 - 29 May 20
- Page 3 and 4: tel-00827710, version 1 - 29 May 20
- Page 5 and 6: tel-00827710, version 1 - 29 May 20
- Page 7 and 8: tel-00827710, version 1 - 29 May 20
- Page 9 and 10: tel-00827710, version 1 - 29 May 20
- Page 11 and 12: tel-00827710, version 1 - 29 May 20
- Page 13 and 14: tel-00827710, version 1 - 29 May 20
- Page 15 and 16: tel-00827710, version 1 - 29 May 20
- Page 17 and 18: tel-00827710, version 1 - 29 May 20
- Page 19 and 20: tel-00827710, version 1 - 29 May 20
- Page 21 and 22: tel-00827710, version 1 - 29 May 20
- Page 23 and 24: tel-00827710, version 1 - 29 May 20
- Page 25 and 26: tel-00827710, version 1 - 29 May 20
- Page 27 and 28: tel-00827710, version 1 - 29 May 20
- Page 29 and 30: tel-00827710, version 1 - 29 May 20
- Page 31 and 32: tel-00827710, version 1 - 29 May 20
- Page 33 and 34: tel-00827710, version 1 - 29 May 20
- Page 35 and 36: tel-00827710, version 1 - 29 May 20
- Page 37 and 38: tel-00827710, version 1 - 29 May 20
- Page 39 and 40: tel-00827710, version 1 - 29 May 20
- Page 41 and 42: tel-00827710, version 1 - 29 May 20
- Page 43 and 44: tel-00827710, version 1 - 29 May 20
- Page 45 and 46: tel-00827710, version 1 - 29 May 20
- Page 47: tel-00827710, version 1 - 29 May 20
- Page 51 and 52: tel-00827710, version 1 - 29 May 20
- Page 53 and 54: tel-00827710, version 1 - 29 May 20
- Page 55 and 56: tel-00827710, version 1 - 29 May 20
- Page 57 and 58: tel-00827710, version 1 - 29 May 20
- Page 59 and 60: tel-00827710, version 1 - 29 May 20
- Page 61 and 62: tel-00827710, version 1 - 29 May 20
- Page 63 and 64: tel-00827710, version 1 - 29 May 20
- Page 65 and 66: tel-00827710, version 1 - 29 May 20
- Page 67 and 68: tel-00827710, version 1 - 29 May 20
- Page 69 and 70: tel-00827710, version 1 - 29 May 20
- Page 71 and 72: tel-00827710, version 1 - 29 May 20
- Page 73 and 74: tel-00827710, version 1 - 29 May 20
- Page 75 and 76: tel-00827710, version 1 - 29 May 20
- Page 77 and 78: tel-00827710, version 1 - 29 May 20
- Page 79 and 80: tel-00827710, version 1 - 29 May 20
- Page 81 and 82: tel-00827710, version 1 - 29 May 20
- Page 83 and 84: tel-00827710, version 1 - 29 May 20
- Page 85 and 86: tel-00827710, version 1 - 29 May 20
- Page 87 and 88: tel-00827710, version 1 - 29 May 20
- Page 89 and 90: tel-00827710, version 1 - 29 May 20
- Page 91 and 92: tel-00827710, version 1 - 29 May 20
- Page 93 and 94: tel-00827710, version 1 - 29 May 20
- Page 95 and 96: tel-00827710, version 1 - 29 May 20
- Page 97 and 98: tel-00827710, version 1 - 29 May 20
tel-00827710, version 1 - 29 May 2013<br />
Figure 9. Effector and memory T cell differentiation upon activation. SLO, secondary lymphoid<br />
organ, SLEC, Short-lived effector cell, MPEC, Memory precursor effector cell, TEM, effector memory<br />
T cell, TCM, central memory T cell. Figure from Cui <strong>et</strong> al. 2010.<br />
(iii) T cell quality<br />
The quality of the T cell response was first characterized by measuring its magnitu<strong>de</strong>,<br />
represented by the frequency of antigen-specific T cells and their ability to secr<strong>et</strong>e IFNγ<br />
following antigen-specific restimulation using techniques such as IFNγ-ELISPOT. However,<br />
the use of only a few param<strong>et</strong>ers to <strong>de</strong>fine the quality of the response and its ability to confer<br />
a protection is often not sufficient (Se<strong>de</strong>r <strong>et</strong> al., 2008). For instance, the magnitu<strong>de</strong> of the<br />
HIV-specific CD8 + T cell response alone does not predict the progression of the disease (Gea-<br />
Banacloche <strong>et</strong> al., 2000). However, by comparing the T cell responses in patients that are<br />
long-term non-progressors to those of progressors, it has been shown that T cell function is<br />
not equivalent b<strong>et</strong>ween these two groups, and that these differences could explain the range of<br />
disease progression and outcome phenotypes in these two patient groups. In general, all the<br />
effector T cells are not functionally i<strong>de</strong>ntical. While some T cells secr<strong>et</strong>e only one cytokine<br />
such as IFNγ, others are able to secr<strong>et</strong>e several cytokines once activated. These polyfunctional<br />
T cells have been <strong>de</strong>monstrated to be critical for mounting an efficient response in multiple<br />
disease mo<strong>de</strong>ls.<br />
Practically speaking, T cells can be characterized both by their surface markers expression<br />
and also by their various functions, including the ability to secr<strong>et</strong>e cytokines, cytolytic activity<br />
or proliferative capacity. The <strong>de</strong>velopment of more advanced techniques such as<br />
Page 49 of 256